Cargando…

Lestaurtinib Inhibition of the JAK/STAT Signaling Pathway in Hodgkin Lymphoma Inhibits Proliferation and Induces Apoptosis

Standard cytotoxic chemotherapy for Hodgkin Lymphoma (HL) has changed little in 30 years; the treatment for patients with relapsed or refractory disease remains challenging and novel agents are under development. JAK/STAT constitutive activation plays an important role in the pathogenesis of HL. Les...

Descripción completa

Detalles Bibliográficos
Autores principales:	Diaz, Tania, Navarro, Alfons, Ferrer, Gerardo, Gel, Bernat, Gaya, Anna, Artells, Rosa, Bellosillo, Beatriz, Garcia-Garcia, Mar, Serrano, Sergi, Martínez, Antonio, Monzo, Mariano
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3080386/ https://www.ncbi.nlm.nih.gov/pubmed/21533094 http://dx.doi.org/10.1371/journal.pone.0018856

Ejemplares similares

MiR-SNPs as Markers of Toxicity and Clinical Outcome in Hodgkin Lymphoma Patients
por: Navarro, Alfons, et al.
Publicado: (2013)

Lestaurtinib Inhibits Histone Phosphorylation and Androgen-Dependent Gene Expression in Prostate Cancer Cells
por: Köhler, Jens, et al.
Publicado: (2012)

Non-Coding RNAs in Hodgkin Lymphoma
por: Cordeiro, Anna, et al.
Publicado: (2017)

Lestaurtinib Has the Potential to Inhibit the Proliferation of Hepatocellular Carcinoma Uncovered by Bioinformatics Analysis and Pharmacological Experiments
por: Wu, Shuang, et al.
Publicado: (2022)

JAK/STAT blockade reverses the malignant phenotype of Hodgkin and Reed-Sternberg cells
por: Fernández, Sara, et al.
Publicado: (2022)

An overview of JAK/STAT pathways and JAK inhibition in alopecia areata
por: Lensing, Maddison, et al.
Publicado: (2022)

Lestaurtinib inhibits Citron kinase activity and medulloblastoma growth through induction of DNA damage, apoptosis and cytokinesis failure
por: Pallavicini, Gianmarco, et al.
Publicado: (2023)

Lestaurtinib induces DNA damage that is related to estrogen receptor activation
por: Ooka, Masato, et al.
Publicado: (2022)

A review of JAK–STAT signalling in the pathogenesis of spondyloarthritis and the role of JAK inhibition
por: McInnes, Iain B, et al.
Publicado: (2021)

PiwiRNA-651 as marker of treatment response and survival in classical Hodgkin lymphoma
por: Cordeiro, Anna, et al.
Publicado: (2016)

The molecular basis of JAK/STAT inhibition by SOCS1
por: Liau, Nicholas P. D., et al.
Publicado: (2018)

Enhancing SHP-1 expression with 5-azacytidine may inhibit STAT3 activation and confer sensitivity in lestaurtinib (CEP-701)-resistant FLT3-ITD positive acute myeloid leukemia
por: Al-Jamal, Hamid Ali Nagi, et al.
Publicado: (2015)

Lestaurtinib is a potent inhibitor of anaplastic thyroid cancer cell line models
por: Pinto, Nicole, et al.
Publicado: (2018)

Pharmacologic inhibition of JAK-STAT signaling promotes hair growth
por: Harel, Sivan, et al.
Publicado: (2015)

Pharmacological inhibition of demethylzeylasteral on JAK-STAT signaling ameliorates vitiligo
por: Chang, Yuqian, et al.
Publicado: (2023)

HSP90 is essential for Jak-STAT signaling in classical Hodgkin lymphoma cells
por: Schoof, Nils, et al.
Publicado: (2009)

Activating JAK1 mutation may predict the sensitivity of JAK-STAT inhibition in hepatocellular carcinoma
por: Yang, Shuqun, et al.
Publicado: (2015)

Transient Inhibition of the JAK/STAT Pathway Prevents B-ALL Development in Genetically Predisposed Mice
por: Casado-García, Ana, et al.
Publicado: (2022)

Inhibition of JAK/STAT signaling stimulates adult satellite cell function
por: Price, Feodor D., et al.
Publicado: (2014)

Feifukang ameliorates pulmonary fibrosis by inhibiting JAK-STAT signaling pathway
por: Li, Hongbo, et al.
Publicado: (2018)

The potential of JAK/STAT pathway inhibition by ruxolitinib in the treatment of COVID-19
por: Goker Bagca, Bakiye, et al.
Publicado: (2020)

Protein Inhibitor of Activated STAT (PIAS) Negatively Regulates the JAK/STAT Pathway by Inhibiting STAT Phosphorylation and Translocation
por: Niu, Guo-Juan, et al.
Publicado: (2018)

NGF-induced TrkA/CD44 association is involved in tumor aggressiveness and resistance to lestaurtinib
por: Aubert, Léo, et al.
Publicado: (2015)

Lestaurtinib potentiates TRAIL‐induced apoptosis in glioma via CHOP‐dependent DR5 induction
por: Cao, Yingxiao, et al.
Publicado: (2020)

JAK2/STAT3 Inhibition Attenuates Noise-Induced Hearing Loss
por: Wilson, Teresa, et al.
Publicado: (2014)

Icaritin Inhibits JAK/STAT3 Signaling and Growth of Renal Cell Carcinoma
por: Li, Shasha, et al.
Publicado: (2013)

JAK–STAT inhibition impairs K‐RAS‐driven lung adenocarcinoma progression
por: Mohrherr, Julian, et al.
Publicado: (2019)

Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis
por: Di Benedetto, Paola, et al.
Publicado: (2021)

Curcumol Attenuates Endometriosis by Inhibiting the JAK2/STAT3 Signaling Pathway
por: Wang, Yan, et al.
Publicado: (2022)

Dihydrotanshinone Inhibits Hepatocellular Carcinoma by Suppressing the JAK2/STAT3 Pathway
por: Hu, Xue, et al.
Publicado: (2021)

Saffron reduces the liver fibrosis in mice by inhibiting the JAK/STAT3 pathway
por: Huang, Lijuan, et al.
Publicado: (2023)

Curcumin induces apoptosis in JAK2‐mutated cells by the inhibition of JAK2/STAT and mTORC1 pathways
por: Petiti, Jessica, et al.
Publicado: (2019)

JAKs and STATs in chemoresistance
por: Costa-Pereira, Ana P
Publicado: (2010)

JAK-STAT and feeding
por: Ladyman, Sharon R., et al.
Publicado: (2013)

IFN-λ3 Inhibits HIV Infection of Macrophages through the JAK-STAT Pathway
por: Liu, Man-Qing, et al.
Publicado: (2012)

Varicella Viruses Inhibit Interferon-Stimulated JAK-STAT Signaling through Multiple Mechanisms
por: Verweij, Marieke C., et al.
Publicado: (2015)

Icaritin suppresses multiple myeloma, by inhibiting IL-6/JAK2/STAT3
por: Zhu, Shicong, et al.
Publicado: (2015)

Expression of nephronectin is inhibited by oncostatin M via both JAK/STAT and MAPK pathways
por: Kurosawa, Tamaki, et al.
Publicado: (2015)

Crocin promotes apoptosis of human skin cancer cells by inhibiting the JAK/STAT pathway
por: Wang, Gongfeng, et al.
Publicado: (2018)

Acteoside inhibits inflammatory response via JAK/STAT signaling pathway in osteoarthritic rats
por: Qiao, Zhiguang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vrochrrfb7b8hqb4inqo0ci11l